() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Category Archives: Asterion

PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property

August 6, 2019 PreveCeutical Medical Inc. (“PreveCeutical”) (CSE: PREV, OTCQB: PRVCF, FSE: 18H), and Asterion Cannabis Inc. (“Asterion”) announce that they have entered into an option to purchase agreement (the “Option Agreement”), whereby PreveCeutical has granted to Asterion the right and option (the“Option”) to purchase up to 51% of PreveCeutical’s right, title and interest in and to certain intellectual property rights relating to a soluble gel (“Sol-Gel”) nasal delivery system for the nose-to-brain delivery of therapeutic formulations, including cannabis and cannabinoids (the “Sol-Gel IP”).
Read more

Government Changes a Big Step Forward for Toowoomba’s Medicinal Cannabis Project

Earlier today, Federal Member for Groom John McVeigh, announced in a media release that Toowoomba’s future as a major global player in the medicinal MJ industry is a step closer, following the announcement by the Morrison Government today that from next month it will prioritise licences for medicinal MJ projects that have been granted Major Project Status.
Read more
Get $50 in free trades.